SCHEMBL21151585

SCHEMBL21151585

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4cccc5c4C4(c6ccccc6Oc6ccccc64)c4ccccc4-5)cc3)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR55 Q9Y2T6 1/20 0.36
L3MBTL1 Q9Y468 4/20 0.34
MAPT P10636 7/20 0.33
MEN1 O00255 6/20 0.33
KMT2A Q03164 6/20 0.33
ALDH1A1 P00352 4/20 0.33
HPGD P15428 3/20 0.33
TSHR P16473 3/20 0.33
ADORA2A P29274 3/20 0.33
ADORA1 P30542 3/20 0.33
ADORA3 P0DMS8 2/20 0.33
ADORA2B P29275 2/20 0.33
ALOX15 P16050 1/20 0.33
SMN1; SMN2 Q16637 6/20 0.33
KDM4E B2RXH2 4/20 0.33
MAPK1 P28482 4/20 0.33
LMNA P02545 3/20 0.33
NFKB1 P19838 3/20 0.33
NFKB2 Q00653 3/20 0.33
RELA Q04206 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21151479 0.93 TSHR (0.35) GPR55L3MBTL1MAPTMEN1KMT2A
SCHEMBL19298860 0.93 GPR55 (0.35) GPR55L3MBTL1MAPTMEN1KMT2A
SCHEMBL21151552 0.93 TSHR (0.37) GPR55L3MBTL1MAPTMEN1KMT2A
SCHEMBL22216545 0.92 MEN1 (0.36) GPR55L3MBTL1MAPTMEN1KMT2A
SCHEMBL21151583 0.92 MAPT (0.42) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL26458422 0.92 MEN1 (0.36) GPR55L3MBTL1MAPTMEN1KMT2A
SCHEMBL22216697 0.92 MEN1 (0.36) GPR55L3MBTL1MAPTMEN1KMT2A
SCHEMBL21152192 0.92 MAPT (0.42) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL26458227 0.92 MEN1 (0.36) GPR55L3MBTL1MAPTMEN1KMT2A
SCHEMBL26458637 0.92 TSHR (0.36) GPR55L3MBTL1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024117762-A1 ORGANIC LIGHT EMITTING DEVICE 주식회사 엘지화학 2024-06-06 WO disclosed
EP-4135005-A1 ORGANIC LIGHT-EMITTING DEVICE SFC Co., Ltd. (KR) 2023-02-15 EP disclosed
US-20210217967-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2021-07-15 US disclosed
WO-2020022811-A1 ORGANIC LIGHT EMITTING DEVICE 주식회사 엘지화학 2020-01-30 WO disclosed
US-20190214571-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214571-A1 ORGANIC LIGHT EMITTING DEVICE PPOX, ERO1A, HMOX2 GPR55 1336/4885L3MBTL1 209/4885MAPT 484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.